Simultaneous copy number gains of NUPR1 and ERBB2 predicting poor prognosis in early-stage breast cancer.

BMC Cancer · 2012 · PMC3489802 · PMID 22938721

Europe PMC DOI

hedged sentence

0.0839

closest p · 1.7× alpha

0.0839

boldest claim

The sentences

borderline significanceP = 0.0839so close (0.05 < p ≤ 0.1)

Patients positive for RAR-G12 ( NUPR1 ) also showed poorer survival than negative patients, but only with borderline significance ( P = 0.0839) (Figure 5 C).

also in 7,017 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.